EMPYREAN BLUE Trademark

Trademark Overview

On Wednesday, October 13, 2021, a trademark application was filed for EMPYREAN BLUE with the United States Patent and Trademark Office. The USPTO has given the EMPYREAN BLUE trademark a serial number of 97072788. The federal status of this trademark filing is ABANDONED - INCOMPLETE RESPONSE as of Monday, May 6, 2024. This trademark is owned by Empyrean Neuroscience, Inc.. The EMPYREAN BLUE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions containing genetically-modified mushroom extracts for treating neurological and mood disorders
empyrean blue

General Information

Serial Number97072788
Word MarkEMPYREAN BLUE
Filing DateWednesday, October 13, 2021
Status600 - ABANDONED - INCOMPLETE RESPONSE
Status DateMonday, May 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical compositions containing genetically-modified mushroom extracts for treating neurological and mood disorders
NOT AVAILABLEBLUE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 3, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmpyrean Neuroscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Trademark Events

Event DateEvent Description
Saturday, October 16, 2021NEW APPLICATION ENTERED
Wednesday, November 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 19, 2022ASSIGNED TO EXAMINER
Wednesday, July 20, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 20, 2022NON-FINAL ACTION E-MAILED
Wednesday, July 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 1, 2023ASSIGNED TO EXAMINER
Tuesday, March 21, 2023NON-FINAL ACTION WRITTEN
Tuesday, March 21, 2023NON-FINAL ACTION E-MAILED
Tuesday, March 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 20, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, June 20, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, September 21, 2023DIVISIONAL REQUEST RECEIVED
Thursday, September 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 21, 2023TEAS REQUEST TO DIVIDE RECEIVED
Friday, September 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 16, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 18, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, October 26, 2023FINAL REFUSAL WRITTEN
Thursday, October 26, 2023FINAL REFUSAL E-MAILED
Thursday, October 26, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, January 25, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, January 25, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, April 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 26, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, April 28, 2024ABANDONMENT - INCOMPLETE RESPONSE
Monday, May 6, 2024ABANDONMENT NOTICE E-MAILED - INCOMPLETE RESPONSE
Monday, May 6, 2024ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE

Related Keywords

blue empyrean treating neurological mood disorders extracts mushroom compositions containing genetically modified